Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin Serum Levels During Cesarean Section
NCT02838940Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of cefazolin in surgical site infection (SSI), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02838940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838940.